NYVRX Mutual Fund

NYVRX Mutual Fund

NAV$31.00
See how much of NYVRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$52M
Expense Ratio
1.20%
Dividend Yield (Current)
0.85%
Holdings
46
Inception Date
Aug 20, 2003
Fund Family
Davis Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Semi-Annually

Performance

YTD+9.58%
1 Year+18.43%
3 Year+24.04%
5 Year+11.27%
10 Year+12.44%

Asset Allocation

Stocks: 97.63%
Cash: 2.37%
See how much of NYVRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
COFCapital One Financial Corp.6.33%
USBUS Bancorp5.31%
DVNDevon Energy Corp.4.96%
CVSCvs Health Corp4.75%
AMZNAmazon.Com Inc4.63%
Top 10 Concentration: 46.10%Report Date: Aug 31, 2026
Download all 46 holdings for NYVRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.85%
Frequency
Semi-Annually
Latest Distribution
$3.51
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

NYVRX Mutual Fund Overview

NYVRX Mutual Fund (Davis New York Venture Fund Class R) is managed by Davis Funds with $51.7M in net assets. NYVRX expense ratio is 1.20%, holding 46 positions across sectors including Financials, Health Care, Consumer Discretionary. Inception date: 2003-08-20.

NYVRX performance shows a YTD return of 9.58%. The 1-year return is 18.43% and the 5-year return is 11.27%. NYVRX dividend yield stands at 0.85%, paid semi-annually.

NYVRX top holdings include Capital One Financial Corp. (6.3%), US Bancorp (5.3%), Devon Energy Corp. (5.0%), Cvs Health Corp (4.8%), Amazon.Com Inc (4.6%). Go to all NYVRX holdings, NYVRX sectors, or NYVRX dividends.

NYVRX can be compared against other funds. Use NYVRX overlap to find shared positions, or NYVRX vs another fund for a side-by-side view. NYVRX alternatives are available via the screener, along with tax-loss harvesting opportunities.